May 5, 2026 11:45AM
Apr 16, 2026 07:44AM
Mar 23, 2026 06:45AM
Mar 23, 2026 06:45AM
Sep 8, 2025 07:22AM
May 7, 2025 01:00AM
Mar 20, 2025 02:00AM Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Mar 26, 2024 02:00AM
Feb 15, 2024 04:16AM
Sep 7, 2023 05:20AM
Mar 23, 2023 05:31AM
Mar 23, 2023 02:00AM
Feb 17, 2023 05:49AM
Feb 17, 2023 01:00AM Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15
Dec 1, 2022 01:00AM
Nov 10, 2022 01:00AM
Aug 11, 2022 01:00AM
Aug 8, 2022 04:47PM
Aug 8, 2022 04:45PM
Aug 8, 2022 04:45PM
Jun 23, 2022 11:45AM Valneva and Pfizer Announce Closing of Equity Investment
Jun 21, 2022 06:11AM
Jun 20, 2022 01:00AM
Jun 20, 2022 01:00AM
May 5, 2022 01:00AM
Apr 26, 2022 06:45AM
Apr 26, 2022 05:41AM
Apr 26, 2022 01:00AM Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
Mar 24, 2022 06:09AM
Mar 24, 2022 02:00AM
Mar 15, 2022 07:01AM
Feb 28, 2022 04:02PM
Feb 8, 2022 06:45AM
Feb 4, 2022 05:27AM
Feb 4, 2022 01:00AM Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate
Dec 16, 2021 09:26AM
Nov 9, 2021 04:01PM
Nov 4, 2021 04:02PM
Nov 2, 2021 06:45AM
Sep 28, 2021 01:00AM
Aug 10, 2021 01:00AM
Aug 4, 2021 04:02PM Dynavax Announces Second Quarter 2021 Financial Results
Jul 28, 2021 06:45AM
Jul 19, 2021 01:00AM

1,197,253 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All